H. Lundbeck A/S Company Profile

H. Lundbeck A/S
Ottiliavej 7-9
DK-2500 Valby
Denmark
Tel: 45/36301311
URL: http://www.lundbeck.com
Primary Symbol & Exchange:
LUN - Ordinary Shares - Copenhagen (Nasadaq OMX Group)
Other Symbol & Exchange:
HLUKY - ADR - Pink Sheets
Industry:
Pharmaceutical
+  SIC Industry Code:
+  NAICS Industry Code:
Mergers & Acquisitions:
H. Lundbeck A/S Mergers and Acquisitions
Thomson Financial Business Description:
The Group's principal activities are the research, development, production, marketing and sale of pharmaceuticals for treating diseases of the central nervous system (CNS). The Group specialises in psychiatry and neurology, focusing exclusively on treatments of psychosis, depression, anxiety, schizophrenia, Parkinson's disease, Alzheimer's disease and dementia. The product group includes Cipralex, Lexapro, Azilect and other pharmaceuticals. The Group operates globally. The Group acquired Ovation Pharmaceuticals,Inc., USA on 9 Feb 2009
Alacra Alerts: H. Lundbeck A/S RSS Feed  Subscribe with My Yahoo!
Receive alerts on the latest reports on H. Lundbeck A/S

Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
Premium Content Results:







Search for more premium content on H. Lundbeck A/S